Evidence map›Paper›PMID 33916994›Full record

ArticleCancers2021

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite.

Raffaela S Berger, Christian J Wachsmuth, Magdalena C Waldhier, Kathrin Renner-Sattler, Simone Thomas, Anuhar Chaturvedi, Hans-Helmut Niller, Elisabeth Bumes, Peter Hau, Martin Proescholdt and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Acidic Microenvironments Found in CutaneousFrontiers in immunology · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Raffaela S BergerInstitute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-5783-3279
Christian J WachsmuthInstitute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.
Magdalena C WaldhierInstitute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.
Kathrin Renner-SattlerDepartment of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
Simone ThomasDepartment of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
Anuhar ChaturvediDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
Hans-Helmut NillerInstitute of Medical Microbiology and Hygiene, University Regensburg, 93053 Regensburg, Germany.
Elisabeth BumesDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0001-6915-3206
Peter HauDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0003-3894-5053
Martin ProescholdtDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.
Wolfram GronwaldInstitute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-3646-0060
Michael HeuserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0001-5318-9044
Marina KreutzDepartment of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
Peter J OefnerInstitute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.
Katja DettmerInstitute of Functional Genomics, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-7337-2380
University Hospital Regensburg · DEUniversity of Regensburg · DEMedizinische Hochschule Hannover · DEInstitute of Medical Microbiology and Hygiene · DE

Funding

Deutsche Forschungsgemeinschaft DFG KFO262European Regional Development Fund Interreg V BY-CZ118
6 · The paper itself

Abstract

In recent years, onco-metabolites like D-2-hydroxyglutarate, which is produced in isocitrate dehydrogenase-mutated tumors, have gained increasing interest. Here, we report a metabolite in human specimens that is closely related to 2-hydroxyglutarate: the intramolecular ester of 2-hydroxyglutarate, 2-hydroxyglutarate-γ-lactone. Using

Indexed as

acute myeloid leukemiaD-2-hydroxyglutarateIDH1/2 mutationlactonization

Identifiers

PMID33916994
PMCPMC8067704
OpenAlexW3143696219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.